The CANS-MCI -- an easy-to-use computer-assisted, touchscreen, cognitive test for mild cognitive impairments

The Computer-Administered Neuropsychological Screen
for mild cognitive impairments

Easily assess your patient’s cognitive health.
Gain higher reimbursements with the CANS-MCI.

  • Tracking "Chemo Brain"

    When cognitive and emotional changes associated with cancer treatment are important to evaluate, baseline data can be compared with post-treatment testing. The CANS-MCI provides the most staff-efficient, objective, longitudinal assessment of cognitive change available today.

  • Concussion Assessment

    The central changes in cognitive ability due to sports concussion are memory, cognitive processing speed, and reaction time — all measured at millisecond accuracy by the CANS-MCI. Our automated administration also eliminates the potential for either the deliberate or unintended bias of in-person testers. Comparison to baseline can be performed before risking a second concussion.

  • Preclinical Diagnosis of AD

    Biomarker research finds CANS-MCI performance predicts both elevated Aβ and tau.  The CANS-MCI captures item-level response times at millisecond accuracy and can detect patterns of delay associated with the preclinical stage of AD.  To read more about this research, click here.

  • Neurological Complications of COVID-19

    Brain fog associated with COVID is a disorder of executive function that makes even basic cognitive tasks complicated; memory can also be affected. The CANS-MCI measures the relevant cognitive dimensions and the influence of depression, making it exceptionally accurate for longitudinal tracking.

Professionally evaluated

Results are reviewed and scored by qualified healthcare professionals.

Reliable & valid

Proven accuracy at levels similar to full neuropsychological workups.

Reimbursable

CPT codes 96132, 96136 and 96137.

Timely reports

Comprehensive, easy-to-read reports are sent back to the practice within an hour.

Longitudinal

Useful as a single baseline screen, or for precise evaluation of longitudinal changes.

Fairly priced

Unlike current industry norms, pay for tests only after they are performed.

The CANS-MCI leads in early detection and awareness of impending dementia.

TELL ME MORE…

Eight distinct tests administered in a single session.

Quick

Takes 30 minutes or less, even for those who are impaired.

Multilingual

Available in English, Spanish, French and Portuguese

No computer skills required

Simple touch screen interactions.  Standardized administration for maximum objectivity and reliability.

Predictive

Screens for the earliest stages of all cognitive declines that are predictive of Alzheimer’s and other dementias.

Efficient

No clinician resources or time required.

Hearing impaired version

Test questions are audible for hearing patients and readable for the hearing impaired.

The following neuropsychological tests were used to assess the validity of the CANS-MCI in studies supported by grants from the Veterans Administration and the National Institute on Aging

  • Wechsler Memory Scale-Revised (WMS-R)
  • Logical Memory Immediate and Delayed (LMS-I and LMS-II)
  • Mattis Dementia Rating Scale (DRS)
  • Wechsler Adult Intelligence Scale, Digit Symbol test
  • (Later validated against the MOCA and MMSE)
  • (Later correlated with CSF amyloid β 1-42 (Aβ) and tau levels)

Hardware Requirements…

 

1

Any Windows operating system


With audio capability, speakers, and video circuitry capable of displaying 640 x 480 resolution with preserved aspect ratio.

 

2

Touchscreen display between 13.3 and 17 inches


For portability and ease-of-use we recommend a “convertible”, “hybrid”, or “2-in-1” notebook / laptop.  Surface Pro tablets (native 2:3 ratio) and point of sale monitors (native 4:3 ratio) are also fine.

 

3

Connection to the Internet


If you don’t have access to the Internet during tests you may upload sessions once you reconnect.
Surface Pro and 2-in-1 hybrid notebook computer

COVID-19 Update

The CANS test requires only a finger touch on a tablet or computer screen, which can be easily sanitized after every test. The test does not require close proximity of patient and staff, significantly reducing the risk of transmission of Covid-19 or other infectious pathogens.